{ "cik": 1133869, "cik_padded": "0001133869", "entityName": "CAPRICOR THERAPEUTICS, INC.", "fiscal_years": [ { "accn": "0001104659-26-029580", "filed": "2026-03-17", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2904461.0, "cash": 287847312.0, "eps_diluted": -2.26, "free_cash_flow": -72715722.0, "net_income": -105043946.0, "operating_cash_flow": -69811261.0, "operating_income": -108142130.0, "stockholders_equity": 305792145.0, "total_assets": 355949294.0, "total_liabilities": 50157149.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1640236671219923, "roa_avg2y": -0.39908010628110024, "roa_period_end": -0.29510929722478957, "roe_avg2y": -0.4655641125921584, "roe_period_end": -0.3435142063573935 } }, { "accn": "0001104659-26-029580", "filed": "2026-03-17", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1166871.0, "cash": 11286996.0, "eps_diluted": -1.15, "free_cash_flow": -41162613.0, "net_income": -40467186.0, "operating_cash_flow": -39995742.0, "operating_income": -42563242.0, "stockholders_equity": 145462336.0, "total_assets": 170481086.0, "total_liabilities": 25018750.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.1719946942141779, "roa_avg2y": -0.35309306185269485, "roa_period_end": -0.2373705315321607, "roe_avg2y": -0.48156932400250396, "roe_period_end": -0.2781970035184915 } }, { "accn": "0001558370-25-003707", "filed": "2026-03-17", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1311660.0, "cash": 14694857.0, "eps_diluted": -0.83, "free_cash_flow": -26908205.0, "net_income": -22287542.0, "operating_cash_flow": -25596545.0, "operating_income": -24077859.0, "stockholders_equity": 22601467.0, "total_assets": 58734327.0, "total_liabilities": 36132860.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.5986953413245255, "roa_avg2y": -0.4095873979158744, "roa_period_end": -0.37946364823419193, "roe_avg2y": -1.2962560502618956, "roe_period_end": -0.9861104148682032 } }, { "accn": "0001558370-25-003707", "filed": "2025-03-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2000243.0, "cash": 9603242.0, "eps_diluted": -1.18, "free_cash_flow": 2916394.0, "net_income": -29019532.0, "operating_cash_flow": 4916637.0, "operating_income": -29697383.0, "stockholders_equity": 11786094.0, "total_assets": 50094910.0, "total_liabilities": 38308816.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.2503402738854787, "roa_avg2y": -0.634825442555886, "roa_period_end": -0.5792910297672957, "roe_avg2y": -1.3449270821795214, "roe_period_end": -2.462183994120529 } }, { "accn": "0001558370-24-002861", "filed": "2024-03-11", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1196286.0, "cash": 34885274.0, "eps_diluted": -0.87, "free_cash_flow": -18005610.0, "net_income": -20022520.0, "operating_cash_flow": -16809324.0, "operating_income": -20938442.0, "stockholders_equity": 31367966.0, "total_assets": 41330323.0, "total_liabilities": 9962357.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.31759652506636865, "roa_avg2y": -0.5272614156327475, "roa_period_end": -0.48445108933699843, "roe_avg2y": -0.6722604093658061, "roe_period_end": -0.638311071875046 } }, { "accn": "0001558370-23-004124", "filed": "2023-03-17", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 547601.0, "cash": 32665874.0, "eps_diluted": -0.88, "free_cash_flow": -10602411.0, "net_income": -13657028.0, "operating_cash_flow": -10054810.0, "operating_income": -13689971.0, "stockholders_equity": 28199784.0, "total_assets": 34618796.0, "total_liabilities": 6419012.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.22762628252755412, "roa_avg2y": -0.5972578804193514, "roa_period_end": -0.3944974862788411, "roe_avg2y": -0.7795291954689566, "roe_period_end": -0.48429548254695853 } }, { "accn": "0001558370-22-003341", "filed": "2022-03-11", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 3899328.0, "free_cash_flow": -6821501.0, "net_income": -7641817.0, "operating_cash_flow": -6821501.0, "operating_income": -7733888.0, "stockholders_equity": 6839386.0, "total_assets": 11113637.0, "total_liabilities": 4274251.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6249465960833326, "roa_avg2y": -0.7506437646403351, "roa_period_end": -0.6876072162515295, "roe_avg2y": -1.3342357070592834, "roe_period_end": -1.1173250054902588 } }, { "accn": "0001104659-21-036410", "filed": "2021-03-15", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 316486.0, "cash": 4259266.0, "eps_diluted": -0.52, "free_cash_flow": -14178927.0, "net_income": -15191095.0, "operating_cash_flow": -13862441.0, "operating_income": -15327086.0, "stockholders_equity": 4615587.0, "total_assets": 9247065.0, "total_liabilities": 4631478.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.0034428990288775, "roa_avg2y": -1.1904848481951271, "roa_period_end": -1.6428017971107591, "roe_avg2y": -1.9177718940047248, "roe_period_end": -3.2912595949334285 } }, { "accn": "0001144204-19-016787", "filed": "2020-03-27", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 32185.0, "cash": 6140135.0, "eps_diluted": 0.09, "free_cash_flow": -14263064.0, "net_income": 2431423.0, "operating_cash_flow": -14230879.0, "operating_income": -12862397.0, "stockholders_equity": 11226855.0, "total_assets": 16273789.0, "total_liabilities": 5046934.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.4495412116750417, "roa_avg2y": 0.13885457311160365, "roa_period_end": 0.1494073076651049, "roe_avg2y": 0.6731793024102188, "roe_period_end": 0.2165720497859819 } }, { "accn": "0001144204-19-016787", "filed": "2019-03-29", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 191970.0, "cash": 3204378.0, "eps_diluted": -1.01, "free_cash_flow": -14646365.0, "net_income": -18806776.0, "operating_cash_flow": -14454395.0, "operating_income": -16976518.0, "stockholders_equity": -4003154.0, "total_assets": 18747355.0, "total_liabilities": 22750509.0 }, "period_end": "2016-12-31", "ratio_units": { "roa_period_end": "ratio" }, "ratios": { "roa_period_end": -1.0031695671202685 } } ], "latest_filing": { "accn": "0001104659-26-029580", "filed": "2026-03-17", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001133869.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001133869.json" }, "ticker": "CAPR" }